OFLOXACIN Side Effects

6005653-2 | Anaemia, Leukopenia, Mouth Ulceration, Neutropenia, Thrombocytopenia
on Dec 09, 2008 Male patient from JAPAN , 69 years of age, was diagnosed with skin ulcer, ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, leukopenia, mouth ulceration, neutropenia, thrombocytopenia. Ofloxacin dosage: . During the same period patient was treated with METOJECT (View Metoject Review and Metoject Label ), FUCIDINE CAP (View Fucidine Cap Review and Fucidine Cap Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), NEXIUM (20mg Gastroresistent Tablets) (View Nexium Review and Nexium Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), AMLOD (View Amlod Review and Amlod Label ), APROVEL (View Aprovel Review and Aprovel Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

5989112-9 | Erythema, Eyelid Oedema, Purpura
Patient was taking Ofloxacin (View Usage). Patient had the following side effects: erythema, eyelid oedema, purpura on Dec 03, 2008 from JAPAN Additional patient health information: Male patient , 87 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?), prophylaxis and. Ofloxacin dosage: . During the same period patient was treated with KARDEGIC (View Kardegic Review and Kardegic Label ). Patient was hospitalized.

5961686-3 | Pneumonia, Respiratory Distress
Adverse event was reported on Nov 04, 2008 by a Female patient taking Ofloxacin (View Usage) (Dosage: 1.5 Mg, Auricular (otic)) was diagnosed with ear infection (What is ear infection?) and. Location: FRANCE , 75 years of age, After Ofloxacin was administered, patient had the following side effects: pneumonia (What is pneumonia?), respiratory distress. During the same period patient was treated with VANCOMYCIN HYDROCHLORIDE (2 Gm, Intravenous (not Otherwise Specified)) (View Vancomycin Hydrochloride Review and Vancomycin Hydrochloride Label ), TICAR (15 Mg, Intravenous (not Otherwise Specified)) (View Ticar Review and Ticar Label ), CIPROFLOXACIN HCL (1200 Mg, Intravenous (not Otherwise Specified)) (View Ciprofloxacin Hcl Review and Ciprofloxacin Hcl Label ), ATARAX (25 Mg, Per Oral) (View Atarax Review and Atarax Label ), ZOLPIDEM TARTRATE (10 Mg, Per Oral) (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ). Patient was hospitalized.

5949978-5 | Anxiety, Chest Pain, Panic Reaction, Paraesthesia
on Nov 10, 2008 Female patient from JAPAN , 30 years of age, was diagnosed with pelvic inflammatory disease (What is pelvic inflammatory disease?) and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), chest pain (What is chest pain?), panic reaction, paraesthesia. Ofloxacin dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ).


5915699-8 | Ear Discomfort, Ear Disorder, Hearing Impaired
on Oct 09, 2008 Male patient from UNITED STATES , weighting 173.0 lb, was treated with Ofloxacin (View Usage). Patient had the following side effects: ear discomfort, ear disorder, hearing impaired. Ofloxacin dosage: 0.3 % Twice Daily Ear.

5903201-6 | Leukocytoclastic Vasculitis
Patient was taking Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: leukocytoclastic vasculitis on Sep 22, 2008 from JAPAN Additional patient health information: Female patient , 65 years of age, was diagnosed with abscess (What is abscess?), hyperthermia and. Ofloxacin dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PROPOFAN (View Propofan Review and Propofan Label ), INNOHEP (View Innohep Review and Innohep Label ), TOPALGIC LP (Controlled/modified Release Sugar-coated Tablets) (View Topalgic Lp Review and Topalgic Lp Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5887762-1 | Pain In Extremity
Adverse event was reported on Aug 22, 2008 by a Female patient taking Ofloxacin (View Usage) (Dosage: 3 Gtt;bid;otic) was diagnosed with ear infection (What is ear infection?) and. Location: UNITED STATES , 60 years of age, Patient experienced the following unwanted or unexpected effects: pain in extremity. Patient was hospitalized.

5862083-1 | Asthenia, Burning Sensation, Chills, Diarrhoea, Dizziness, Dry Mouth, Dysphagia, Dysphonia, Dyspnoea
on Aug 27, 2008 Female patient from UNITED STATES , 43 years of age, weighting 220.0 lb, was diagnosed with ear infection (What is ear infection?) and was treated with Ofloxacin (View Usage). Patient had the following side effects: asthenia, burning sensation, chills, diarrhoea, dizziness (What is dizziness?), dry mouth, dysphagia, dysphonia, dyspnoea. Ofloxacin dosage: 10 Drops Each Ear 2 Times Daily. Patient was hospitalized.

5717851-3 | Ventricular Tachycardia
on Apr 14, 2008 Male patient from UNITED KINGDOM , 59 years of age, was diagnosed with prostatitis and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: ventricular tachycardia. Ofloxacin dosage: . Patient was hospitalized.

5711415-3 | Anxiety, Panic Attack, Tearfulness
Patient was taking Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), panic attack, tearfulness on Apr 10, 2008 from UNITED KINGDOM Additional patient health information: Female patient , 28 years of age, was diagnosed with pelvic inflammatory disease (What is pelvic inflammatory disease?) and. Ofloxacin dosage: . During the same period patient was treated with DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), METRONIDAZOLE HCL (View Metronidazole Hcl Review and Metronidazole Hcl Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ).

5709080-4 | Agitation, Confusional State, Memory Impairment
Adverse event was reported on Apr 07, 2008 by a Female patient taking Ofloxacin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?), hypertension, chondrocalcinosis, depression (What is depression?) and. Location: FRANCE , 87 years of age, Patient had the following side effects: agitation, confusional state, memory impairment. During the same period patient was treated with APPROVEL (View Approvel Review and Approvel Label ), COLCHICINE (View Colchicine Review and Colchicine Label ), VENLAFAXINE HCL (View Venlafaxine Hcl Review and Venlafaxine Hcl Label ). Patient was hospitalized.

5684097-7 | Clostridium Difficile Colitis
on Mar 17, 2008 Female patient from SPAIN , 31 years of age, was diagnosed with abdominal pain (What is abdominal pain?) and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: clostridium difficile colitis. Ofloxacin dosage: Dose: Unk. During the same period patient was treated with METRONIDAZOLE HCL (Dose: Unk) (View Metronidazole Hcl Review and Metronidazole Hcl Label ), CIPROFLOXACIN (Dose: Unk) (View Ciprofloxacin Review and Ciprofloxacin Label ).

5610849-5 | Toxic Anterior Segment Syndrome
on Jan 22, 2008 Female patient from UNITED KINGDOM , 58 years of age, was diagnosed with postoperative care, preoperative care, prophylaxis and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: toxic anterior segment syndrome. Ofloxacin dosage: . During the same period patient was treated with DEXAMETHASONE TAB (View Dexamethasone Tab Review and Dexamethasone Tab Label ), OCUFEN (View Ocufen Review and Ocufen Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), GLYCEROL 2.6% (View Glycerol 2.6% Review and Glycerol 2.6% Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ).

5602378-X | Hyponatraemia
Patient was taking Ofloxacin (View Usage). Patient had the following side effects: hyponatraemia on Jan 16, 2008 from FRANCE Additional patient health information: Female patient , 51 years of age, was diagnosed with infection prophylaxis, autoimmune hepatitis, oesophageal varices haemorrhage and. Ofloxacin dosage: . During the same period patient was treated with CORTANCYL (View Cortancyl Review and Cortancyl Label ), NEXIUM (View Nexium Review and Nexium Label ), GLYPRESSINE (View Glypressine Review and Glypressine Label ), INEXIUM (View Inexium Review and Inexium Label ), XANAX (View Xanax Review and Xanax Label ). Patient was hospitalized.

5597414-3 | Leukocytoclastic Vasculitis, Purpura
Adverse event was reported on Jan 10, 2008 by a Female patient taking Ofloxacin (View Usage) (Dosage: ) was diagnosed with abscess (What is abscess?), hyperthermia and. Location: FRANCE , 65 years of age, After Ofloxacin was administered, patient had the following side effects: leukocytoclastic vasculitis, purpura. During the same period patient was treated with TOPALGIC LP (View Topalgic Lp Review and Topalgic Lp Label ), RIFADIN (View Rifadin Review and Rifadin Label ), PROPOFAN (View Propofan Review and Propofan Label ), INNOHEP (View Innohep Review and Innohep Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5594523-X | Acute Febrile Neutrophilic Dermatosis
on Jan 10, 2008 Female patient from TURKEY , 40 years of age, was diagnosed with diarrhoea haemorrhagic and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis. Ofloxacin dosage: .

5576076-5 | Intracranial Pressure Increased, Papilloedema, Visual Disturbance
on Dec 11, 2007 Male patient from FRANCE , 77 years of age, was treated with Ofloxacin (View Usage). Patient had the following side effects: intracranial pressure increased, papilloedema, visual disturbance. Ofloxacin dosage: Per Oral. Patient was hospitalized.

5514194-8 | Cardiac Arrest, Dermatitis Bullous
Patient was taking Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), dermatitis bullous on Nov 08, 2007 from FRANCE Additional patient health information: Female patient , 97 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Ofloxacin dosage: .

5512699-7 | Blood Gases Abnormal, Cogwheel Rigidity, Confusional State, Depressed Level Of Consciousness, Disorientation, Dysphagia, Echolalia, Echopraxia, Hallucination
Adverse event was reported on Oct 22, 2007 by a Female patient taking Ofloxacin (View Usage) (Dosage: (400 Mg Qd Intravenous)) was diagnosed with pyelonephritis acute and. Location: TURKEY , 50 years of age, Patient experienced the following unwanted or unexpected effects: blood gases abnormal, cogwheel rigidity, confusional state, depressed level of consciousness, disorientation, dysphagia, echolalia, echopraxia, hallucination. Patient was hospitalized.

5512697-3 | Blood Gases Abnormal, Cogwheel Rigidity, Confusional State, Depressed Level Of Consciousness, Disorientation, Dysphagia, Echolalia, Echopraxia, Irritability
on Oct 22, 2007 Male patient from TURKEY , 75 years of age, was treated with Ofloxacin (View Usage). Patient had the following side effects: blood gases abnormal, cogwheel rigidity, confusional state, depressed level of consciousness, disorientation, dysphagia, echolalia, echopraxia, irritability. Ofloxacin dosage: (400 Mg Qd). Patient was hospitalized.

5511038-5 | Neutropenia
on Oct 30, 2007 Male patient from FRANCE , 40 years of age, was diagnosed with gastric ulcer and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: neutropenia. Ofloxacin dosage: . During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), NOZINAN (View Nozinan Review and Nozinan Label ), PERFALGAN (View Perfalgan Review and Perfalgan Label ), OGASTORO (View Ogastoro Review and Ogastoro Label ), HUMALOG (View Humalog Review and Humalog Label ), HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), PROPOFOL (View Propofol Review and Propofol Label ), NIMBEX (View Nimbex Review and Nimbex Label ). Patient was hospitalized.

5509038-4 | Cardiac Arrest, Dermatitis Bullous
Patient was taking Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), dermatitis bullous on Nov 06, 2007 from FRANCE Additional patient health information: Female patient , 97 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Ofloxacin dosage: .

5493096-X | Toxic Anterior Segment Syndrome
Adverse event was reported on Oct 12, 2007 by a Female patient taking Ofloxacin (View Usage) (Dosage: ) was diagnosed with postoperative care, preoperative care, prophylaxis and. Location: UNITED KINGDOM , 58 years of age, Patient had the following side effects: toxic anterior segment syndrome. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), OCUFEN (View Ocufen Review and Ocufen Label ), CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), GLYCEROL 2.6% (View Glycerol 2.6% Review and Glycerol 2.6% Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), LIDOCAINE (View Lidocaine Review and Lidocaine Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ).

5488993-5 | Toxic Anterior Segment Syndrome
on Oct 03, 2007 Female patient from UNITED KINGDOM , 58 years of age, was diagnosed with postoperative care, preoperative care and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: toxic anterior segment syndrome. Ofloxacin dosage: . During the same period patient was treated with CYCLOPENTOLATE HCL (View Cyclopentolate Hcl Review and Cyclopentolate Hcl Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), GLYCEROL 2.6% (View Glycerol 2.6% Review and Glycerol 2.6% Label ), HYALURONATE SODIUM (View Hyaluronate Sodium Review and Hyaluronate Sodium Label ), LIDOCAINE HYDROCHLORIDE (View Lidocaine Hydrochloride Review and Lidocaine Hydrochloride Label ), FLURBIPROFEN SODIUM (View Flurbiprofen Sodium Review and Flurbiprofen Sodium Label ), PHENYLEPHRINE (View Phenylephrine Review and Phenylephrine Label ), POVIDONE IODINE (View Povidone Iodine Review and Povidone Iodine Label ).

5486563-6 | Arthropathy
on Jun 25, 2007 Male patient from INDIA , child 8 years of age, was diagnosed with typhoid fever, pyrexia and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: arthropathy. Ofloxacin dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

5445984-8 | Arthralgia, Arthropathy
Patient was taking Ofloxacin (View Usage). Patient had the following side effects: arthralgia, arthropathy on Aug 29, 2007 from INDIA Additional patient health information: Male patient , child 8 years of age, weighting 52.91 lb, was diagnosed with typhoid fever, pyrexia and. Ofloxacin dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

5409362-X | Acute Febrile Neutrophilic Dermatosis
Adverse event was reported on Jul 30, 2007 by a Female patient taking Ofloxacin (View Usage) (Dosage: ) . Location: UNITED STATES , 40 years of age, After Ofloxacin was administered, patient had the following side effects: acute febrile neutrophilic dermatosis.

5391086-9 | Cogwheel Rigidity, Confusional State, Dysphagia, Hallucination, Irritability, Psychotic Disorder, Salivary Hypersecretion
on Jul 11, 2007 Female patient from TURKEY , 50 years of age, was diagnosed with pyelonephritis acute and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: cogwheel rigidity, confusional state, dysphagia, hallucination, irritability, psychotic disorder (What is psychotic disorder?), salivary hypersecretion. Ofloxacin dosage: .

5391085-7 | Cogwheel Rigidity, Confusional State, Dysphagia, Irritability, Loss Of Consciousness, Salivary Hypersecretion
on Jul 11, 2007 Male patient from TURKEY , 75 years of age, was treated with Ofloxacin (View Usage). Patient had the following side effects: cogwheel rigidity, confusional state, dysphagia, irritability, loss of consciousness, salivary hypersecretion. Ofloxacin dosage: .

5383079-2 | Arthropathy, Gait Disturbance
Patient was taking Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: arthropathy, gait disturbance on Jun 20, 2007 from INDIA Additional patient health information: Male patient , child 8 years of age, was diagnosed with typhoid fever and. Ofloxacin dosage: 15 Mg/kg, Qd, Oral. During the same period patient was treated with PARACETAMOL (ACETAMINOPHEN/PARACETAMOL) (View Paracetamol (acetaminophen/paracetamol) Review and Paracetamol (acetaminophen/paracetamol) Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ).

5379954-5 | Arthropathy
Adverse event was reported on Jun 25, 2007 by a Male patient taking Ofloxacin (View Usage) (Dosage: ) was diagnosed with typhoid fever, pyrexia and. Location: INDIA , child 8 years of age, Patient experienced the following unwanted or unexpected effects: arthropathy. During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

5374708-8 | Arthralgia, Arthropathy
on Jun 19, 2007 Male patient from INDIA , child 8 years of age, was diagnosed with typhoid fever, pyrexia and was treated with Ofloxacin (View Usage). Patient had the following side effects: arthralgia, arthropathy. Ofloxacin dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ).

5327089-X | Clonus, Eye Rolling, Petit Mal Epilepsy, Urinary Incontinence
on May 07, 2007 Female patient from UNITED KINGDOM , 17 years of age, was diagnosed with pelvic inflammatory disease (What is pelvic inflammatory disease?), contraception and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: clonus, eye rolling, petit mal epilepsy, urinary incontinence (What is urinary incontinence?). Ofloxacin dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MICROGYNON (View Microgynon Review and Microgynon Label ).

5311041-4 | Muscle Spasms
Patient was taking Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: muscle spasms on Apr 18, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 77 years of age, . Ofloxacin dosage: . During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BENDROFLUMETHAZIDE (View Bendroflumethazide Review and Bendroflumethazide Label ), BISOPRODOL FUMARATE (View Bisoprodol Fumarate Review and Bisoprodol Fumarate Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), INSULIN (View Insulin Review and Insulin Label ).

5310298-3 | Muscle Spasms
Adverse event was reported on Apr 05, 2007 by a Male patient taking Ofloxacin (View Usage) (Dosage: 400 Mg, Bid, Oral) . Location: UNITED KINGDOM , 77 years of age, weighting 200.0 lb, Patient had the following side effects: muscle spasms. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), BENDROFLUMETHIAZIDE (BENDROFLUMETHIAZIDE) (View Bendroflumethiazide (bendroflumethiazide) Review and Bendroflumethiazide (bendroflumethiazide) Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CARDURA (View Cardura Review and Cardura Label ), EZETIMIBE (View Ezetimibe Review and Ezetimibe Label ), HUMULIN M3 (View Humulin M3 Review and Humulin M3 Label ), LISINOPRIL (LISNOPRIL) (View Lisinopril (lisnopril) Review and Lisinopril (lisnopril) Label ).

5309083-8 | Muscle Spasms
on Apr 05, 2007 Male patient from UNITED KINGDOM , 77 years of age, was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: muscle spasms. Ofloxacin dosage: 800 Mg (400 Mg, 2 In 1 D); Oral.

5180261-4 | Tuberculosis
on Nov 27, 2006 Female patient from SINGAPORE , 37 years of age, was diagnosed with productive cough and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: tuberculosis (What is tuberculosis?). Ofloxacin dosage: Unk, Unk, Unk. During the same period patient was treated with CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ). Patient was hospitalized.

5103634-4 | Anorexia, Arthralgia, Heart Rate Increased, Hypoaesthesia, Joint Swelling, Nausea, Palpitations
Patient was taking Ofloxacin (View Usage). Patient had the following side effects: anorexia, arthralgia, heart rate increased, hypoaesthesia, joint swelling, nausea (What is nausea?), palpitations on Sep 04, 2006 from JAPAN Additional patient health information: Female patient , 28 years of age, was diagnosed with pelvic infection and. Ofloxacin dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized and became disabled.

5030886-1 | Corneal Deposits
Adverse event was reported on Jun 09, 2006 by a Female patient taking Ofloxacin (View Usage) (Dosage: Ophthalmic) was diagnosed with ulcerative keratitis and. Location: UNITED KINGDOM , 83 years of age, After Ofloxacin was administered, patient had the following side effects: corneal deposits. During the same period patient was treated with CYCLOPENTOLATE HYDROCHLORIDE(CYCLOPENTOLATE HYDROCHLORIDE) (View Cyclopentolate Hydrochloride(cyclopentolate Hydrochloride) Review and Cyclopentolate Hydrochloride(cyclopentolate Hydrochloride) Label ).

5029120-8 | Acute Febrile Neutrophilic Dermatosis, Haemoglobin Decreased, Headache, Myalgia
on May 31, 2006 Female patient from TURKEY , 40 years of age, was diagnosed with diarrhoea, diarrhoea haemorrhagic and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis, haemoglobin decreased, headache (What is headache?), myalgia. Ofloxacin dosage: 400 Mg Qday. Patient was hospitalized.

5009937-6 | Corneal Deposits
on May 08, 2006 Male patient from UNITED KINGDOM , 73 years of age, was diagnosed with uveitis and was treated with Ofloxacin (View Usage). Patient had the following side effects: corneal deposits. Ofloxacin dosage: Topical. During the same period patient was treated with DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), FUCITHALMIC (FUCITHALMIC) (View Fucithalmic (fucithalmic) Review and Fucithalmic (fucithalmic) Label ), CYCLOPENTOLATE (CYCLOPENTOLATE) (View Cyclopentolate (cyclopentolate) Review and Cyclopentolate (cyclopentolate) Label ).

5009559-7 | Corneal Deposits
Patient was taking Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: corneal deposits on May 08, 2006 from UNITED KINGDOM Additional patient health information: Female patient , 83 years of age, was diagnosed with ulcerative keratitis and. Ofloxacin dosage: Hourly, Topical. During the same period patient was treated with CYCLOPENTOLATE (CYCLOPENTOLATE) (View Cyclopentolate (cyclopentolate) Review and Cyclopentolate (cyclopentolate) Label ), GENTAMICIN (Topical) (View Gentamicin Review and Gentamicin Label ), CEROXIM (CEFUROXIME AXETIL) (Topical) (View Ceroxim (cefuroxime Axetil) Review and Ceroxim (cefuroxime Axetil) Label ).

5009558-5 | Corneal Deposits, Corneal Disorder, Ocular Toxicity
Adverse event was reported on May 08, 2006 by a Male patient taking Ofloxacin (View Usage) (Dosage: Topical) was diagnosed with corneal abrasion and. Location: UNITED KINGDOM , 51 years of age, Patient experienced the following unwanted or unexpected effects: corneal deposits, corneal disorder, ocular toxicity. During the same period patient was treated with GENTAMICIN (View Gentamicin Review and Gentamicin Label ), CHLORAMPHENICOL (Topical) (View Chloramphenicol Review and Chloramphenicol Label ), CYCLOPENTOLATE (CYCLOPENTOLATE) (View Cyclopentolate (cyclopentolate) Review and Cyclopentolate (cyclopentolate) Label ).

5009557-3 | Corneal Deposits
on May 08, 2006 Male patient from UNITED KINGDOM , 89 years of age, was diagnosed with ulcerative keratitis and was treated with Ofloxacin (View Usage). Patient had the following side effects: corneal deposits. Ofloxacin dosage: Topical. During the same period patient was treated with CYCLOPENTOLATE (CYCLOPENTOLATE) (Topical) (View Cyclopentolate (cyclopentolate) Review and Cyclopentolate (cyclopentolate) Label ).

5009555-X | Corneal Deposits
on May 08, 2006 Female patient from UNITED KINGDOM , 82 years of age, was diagnosed with ulcerative keratitis, glaucoma (What is glaucoma?) and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: corneal deposits. Ofloxacin dosage: Topical. During the same period patient was treated with LATANOPROST (View Latanoprost Review and Latanoprost Label ), CYCLOPENTOLATE (CYCLOPENTOLATE) (Topical) (View Cyclopentolate (cyclopentolate) Review and Cyclopentolate (cyclopentolate) Label ).

4984269-0 | Anxiety, Asthenia, Emotional Disorder, Palpitations, Personality Change, Sleep Disorder, Vision Blurred
Patient was taking Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), asthenia, emotional disorder, palpitations, personality change, sleep disorder (What is sleep disorder?), vision blurred on Apr 18, 2006 from JAPAN Additional patient health information: Female patient , 37 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and. Ofloxacin dosage: .

4975165-3 | Eye Swelling, Lacrimation Increased, Ocular Hyperaemia, Photophobia, Vision Blurred, Visual Disturbance
Adverse event was reported on Apr 17, 2006 by a Female patient taking Ofloxacin (View Usage) (Dosage: 1-2 Drops 4 Times Daily Ophthalmic) was diagnosed with conjunctivitis infective and. Location: UNITED STATES , 29 years of age, weighting 120.0 lb, Patient had the following side effects: eye swelling, lacrimation increased, ocular hyperaemia, photophobia, vision blurred, visual disturbance.

4970799-4 | Grand Mal Convulsion
on Aug 10, 2005 Male patient from UNITED STATES , 40 years of age, was diagnosed with bacterial infection (What is bacterial infection?) and was treated with Ofloxacin (View Usage). After Ofloxacin was administered, patient had the following side effects: grand mal convulsion. Ofloxacin dosage: 300 Mg.

4964963-8 | Dysphonia, Feeling Hot, Hypersensitivity, Tremor
on Mar 20, 2006 Female patient from PORTUGAL , 36 years of age, was diagnosed with ovarian cyst (What is ovarian cyst?) and was treated with Ofloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: dysphonia, feeling hot, hypersensitivity, tremor. Ofloxacin dosage: 200 Mg, Qd, Oral.

4952828-7 | Anorexia, Arthralgia, Heart Rate Increased, Hypoaesthesia, Joint Swelling, Nausea, Palpitations
Patient was taking Ofloxacin (View Usage). Patient had the following side effects: anorexia, arthralgia, heart rate increased, hypoaesthesia, joint swelling, nausea (What is nausea?), palpitations on Mar 14, 2006 from JAPAN Additional patient health information: Female patient , 28 years of age, was diagnosed with pelvic infection and. Ofloxacin dosage: . During the same period patient was treated with METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ). Patient was hospitalized.